"Rarely in basic or clinical research do we have the thrill of seeing results translated into therapies that transform lives. Such an opportunity now exists within the Stanford Institute of Neuro-innovation and Translational Neurosciences where critical discoveries in the laboratory are being translated into viable treatment strategies for patients and their families."
- Craig Heller, PhD, Director
Inaugural Down Syndrome Conference
Friday, October 28, 2022
Importance, Challenges, and Latest Interventions of Sleep
DOWNLOAD DR. PELAYO'S PRESENTATION
Download Dr. Okorie's Presentatation
Dual Diagnosis of Down syndrome and Autism
Noemi Spinazzi, Co-Chair, DSMIG DS-Autism Dual Diagnosis Subcommittee and Medical Director, UCSF Benioff Children’s Hospital Oakland Down syndrome clinic
Teresa Unnerstall, Author of “A New Course: A Mother’s Journey Navigating Down Syndrome And Autism”
Please visit The Matthew Foundation website for the presentation slides.
We want your input!
We are re-invigorating and expanding our research center to improve the quality of life of individuals with Down syndrome. We invite your input on the initial version of the mission statement that will guide our work.
If you would like to be involved or contribute, please click below or email us at info_sdsrc [at] stanford.edu.
Our Mission
Our mission is to help people with Down syndrome lead healthier and happier lives by rapidly and effectively applying research discoveries to useful treatments.
Down Syndrome Resources
Families with a member with Down syndrome face many challenges and have many questions. We present on this website an extensive and curated collection of references, articles, blogs, news articles, and essays that will be valuable sources of information.
COVID-19 Information
Question and Answers (Q&A) on COVID-19 have been developed to help you support your loved one with Down syndrome. These documents have been endorsed by all the United States Down syndrome organizations, the Jerome Lejeune Foundation, and Trisomy 21 Research Society.